A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

NCT01545440 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

258

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma

Interventions

DRUG: lebrikizumab
DRUG: lebrikizumab
DRUG: lebrikizumab
DRUG: placebo

Sponsor

Genentech, Inc.